We were honored to see Hemex Health, Inc. Health and the Gazelle® platform* featured in this Kenyan national news segment as part of an important initiative expanding access to sickle cell screening and care in Kenya. On April 29, Hemex Health’s Gazelle® platform was featured during a newborn screening training initiative in the Kisumu and Nyanza regions of Kenya, with the goal of expanding access to sickle cell disease diagnostics and care. The event brought together nurses, community health workers, and representatives from Kenya's Ministry of Health (MOH), including Dr.Yvet Kisaka; Selina Olwanda, CEO of the @Children’s Sickle Cell Foundation; Mr. Abdou Salam of Fondation Pierre Fabre; and Emily Gumbo, CEO of the Sickle Cell Federation of Kenya, to strengthen diagnostic capacity at Level 3 and 4 county hospitals. As part of an ongoing collaboration with the MOH and AMPATH Kenya, Gazelle has been incorporated into the Afya Dhabiti program to support screening efforts for 2,000 infants ages 0–5 in Migori, Siaya, and Trans-Nzoia counties, while also supporting hydroxyurea monitoring and long-term disease management through stakeholder engagement and collaboration. #SickleCellDisease #NewbornScreening #GlobalHealth #Diagnostics #HemexHealth #Gazelle *Product not for sale in the US
Hemex Health, Inc.
Medical Equipment Manufacturing
Portland, OR 6,647 followers
Diagnostics that empower the new front lines of healthcare
About us
Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized to make diagnostics more accessible at the front lines of healthcare. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need. The company’s leaders, with backgrounds in international business and biomedical engineering, have decades of success in developing and delivering more than 60 products that have made a difference in people’s lives. We leverage our experience in building successful medical products to solve major needs in global health. Our low-cost technologies are targeted for the developing world and can impact millions by identifying diseases which can be affordably treated. Hemex is developing a diagnostic platform (utilizing technology which received a 2016 Patents for Humanity Award) that can quickly and easily diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a drop of blood. The solution provides point-of-care access to diagnostic information faster, more cost-effectively, and more accurately than any solution on the market today. Hemex is an equal opportunity employer. All employment-related decisions are based solely upon one’s individual merit and qualifications directly related to professional competence, and without regard to race, color, religion, national origin, pregnancy status, sex (gender}, age, marital status, mental or physical disability, sexual orientation, gender identity, military or veteran status, genetic history, or any other characteristic or classification protected by applicable law. We will also attempt to reasonably accommodate an individual based on his/her physical or mental limitation or because of the individual’s sincerely held religious beliefs.
- Website
-
http://www.hemexhealth.com
External link for Hemex Health, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Portland, OR
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Diagnostics, Sickle Cell Disease, and Beta Thalassemia
Locations
-
Primary
Get directions
4640 SW Macadam Avenue
Suite 250
Portland, OR 97239, US
Employees at Hemex Health, Inc.
Updates
-
It was incredibly valuable to attend the American Society for Apheresis (ASFA) meeting and see how red blood cell exchange is advancing care for patients with sickle cell disease — and how important timely hemoglobin data can be in supporting these workflows. Shown here is Jack Fischer, Global Product Manager at Hemex Health, Inc., with Dr. John Manis at Boston Children’s Hospital, who is currently working to better understand how red blood cell exchange (RBCx) can be made more efficient and personalized for each sickle cell patient. Gazelle Products not for sale in the US #Gazelle #HemexHealth #PointofCare #SickleCellDisease #SCD #EarlyDiagnosis
-
-
This International Thalassaemia Day, Hemex Health, Inc. joins the global call to make thalassaemia #HiddenNoMore by expanding access to timely, accurate diagnostic insights that help clinicians make informed treatment decisions and improve patient care worldwide. Hemex Health products not for sale in the US* #InternationalThalassaemiaDay #ThalassaemiaAwareness #BloodTransfusions #HemexHealth Thalassaemia International Federation (TIF)
-
-
Excited to be part of this event alongside so many other great Oregon companies! #Gazelle #SickleCell #OregonInnovation Oregon Bioscience Incubator and OTRADI
What a lineup for the upcoming Oregon Innovation Showcase! We are thrilled to see many Oregon Bioscience Incubator and OTRADI startups and alumni presenting on stage: Trace Biosciences, Madorra Inc., Caravel Bio, Vivifi Medical, Thaena, SurgiVance Inc Plus, here are the OBI startups being highlighted as emerging and mid-stage startups: Caravel Bio, Hemex Health, Inc., Orygyn Medical Devices, SurgiVance Inc, Thaena, Trace Biosciences, Vivifi Medical In addition to these and the many other amazing startups being showcased, we are excited to hear from our community partners and champions as speakers: Tobias Read, Cara Turano (emcee!), Jordana Barclay, Sophorn Cheang, MBA, Steve Eichenlaub, Angela Jackson, Jenn Lynch, Yalda Moshiri, Holly Rockweiler, Melanie (Mel) Strong and NEXT VENTŪRES, and many more! We are proud to support this event as a sponsor and to be represented as a Center of Innovation Excellence Ecosystem Partner. I hope to see you there for this exciting celebration of innovation! https://lnkd.in/ghRHTagU
-
-
Great to see this training from the inspirational team in Kenya! Very committed to growing the capabilities here .
What a wonderful day! Stakeholders engagement and training of HCP in Kisumu county by Children Sickle Cell Foundation under the guidance of Selina Olwanda Ogweno and Dr. Yvette Kisaka of the MOH. Thank you Haroun Ayub, Bsc. MLS from Keton Consulting Limited for a fantastic job done with the #gazelle Hb electrophoresis Sickle Cell Federation of Kenya #sicklecellanemia. Hemex Health, Inc. “ we keep impacting society”
-
-
Hemex Health, Inc. reposted this
Exciting to see Gazelle reaching more patients to diagnose and monitor treatment of patients with SCD. Thanks for ZACCAF/HFZ and Novo Nordisk Haemophilia & Haemoglobinopathies Foundation for their support.
We are proud to mark a historic milestone for Muchinga Province. ZACCAF/HFZ successfully handed over the first-ever Gazelle Hb Electrophoresis Machine to Chinsali General Hospital, a significant advancement in strengthening diagnostic capacity in the region. The equipment was officially received by the Provincial Health Director Dr. David Silweya, together with the Senior Medical Superintendent, Dr. Aaron Nyirenda. This development enables accurate, timely diagnosis of hemoglobin disorders such as sickle cell disease and prometes New Born Screening within the Province, reducing delays and the need for referrals outside Muchinga, while improving patient outcomes and care. This milestone has been made possible through the generous support of Novo Nordisk Haemophilia & Haemoglobinopathies Foundation. We are grateful for their continued commitment to improving access to quality healthcare. Together with our partners and stakeholders, we remain committed to strengthening health systems and delivering impact where it matters most. #ZACCAF #HealthcareInnovation #PublicHealth #Partnerships #Impact #MuchingaProvince
-
-
-
-
-
+1
-
-
Hemex Health, Inc. is proud to support the launch of the #SC360 campaign ahead of #WorldHealthDay featuring real stories from #SickleCellDisease patients, caregivers, advocates & professionals—because every perspective matters. #SickleCell360 brings these voices together in one interactive platform, offering a 360- degree look at how sickle cell disease affects lives across the world and how the disease progresses and evolves over time. Through stories, expert interviews, and personal reflections, the campaign showcases the resilience of the sickle cell community and the collective strength driving progress. Start exploring at: https://lnkd.in/ekYnXVBe #GetToKnowSickleCell #SickleCellAwareness #HealthForAll #WorldHealthDay
-
-
Hemex Health, Inc. reposted this
Health is not limited by borders - it’s a shared global responsibility, and it should be accessible, equitable, and a priority for all. This #WorldHealthDay, as the theme aligns with building healthier futures, it’s time to stand with science - understand it, trust it, and adopt innovations that drive better outcomes.🌍💙 Hemex Health, Inc. Patti White Peter Galen #WorldHealthDay #HealthForAll #AccessibleHealthcare #Diagnostics #InnovationInHealth #Gazelle #GlobalHealth
-
-
We’re proud to see our CEO, Patti White, featured in this thoughtful conversation hosted by Terumo Blood and Cell Technologies in recognition of International Women’s Day. This discussion is about the everyday decisions that shape culture, build trust, and create opportunities for others to grow. Thank you to Terumo for bringing together such a powerful group of leaders and for highlighting the importance of lifting others as we rise. We invite you to watch and reflect on what “give to gain” means in your own journey.
What does it truly mean to give to gain — especially for women navigating growth, change, and leadership? In this International Women’s Day LinkedIn Live conversation, Antoinette Gawin, CEO of Terumo Blood and Cell Technologies, brings together three remarkable leaders in healthcare and science — Patti White (Hemex Health, Inc.), Cate Dyer Spears (CGT Global), and Kelly Brough (Fitzsimons Innovation Community) — for a candid discussion about courage, purpose and the responsibility of lifting others as we rise. Together, they’ll explore the moments that shape real growth — the advice given, uncertainty faced, and the small, everyday choices that shape cultures where people feel seen, trusted, and empowered. This conversation is open to all and designed to support and inspire women and all career professionals at every stage of their journey. Click “Attend” and join us — live or on demand!
International Women's Day CEO Panel | Terumo Blood and Cell Technologies
www.linkedin.com
-
Hemex Health, Inc. reposted this
🌟 Hemex Health, Inc. has been granted Breakthrough Device Designation by the U.S.FDA for their Gazelle Hb Variant Test! 🩸 The Gazelle platform rapidly detects and quantifies important blood-based conditions with the goal of decentralizing access to quantitative hemoglobin data. Hemex is exploring how this technology may support monitoring and management of sickle cell disease and other related illnesses. The FDA Breakthrough Devices Program accelerates the review process of medical devices that may provide more effective diagnosis or treatment of certain diseases, providing patients and providers timely access to these devices. We're proud to see one of our portfolio companies continue to innovate and achieve this meaningful regulatory milestone – congratulations, team! 🔗 Press release: https://ow.ly/ItAx50YbRmS Congrats Patti White! #MedTech #Innovation #Pediatrics #CTIP
-